# HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease

> **NCT01141205** · PHASE1 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 18 (actual)

## Conditions studied

- Aids, Cdc Group I

## Interventions

- **BIOLOGICAL:** AFO-18
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01141205
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01141205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01141205, "HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT01141205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*